Publication | Closed Access

Hydrangenol inhibits lipopolysaccharide-induced nitric oxide production in BV2 microglial cells by suppressing the NF-κB pathway and activating the Nrf2-mediated HO-1 pathway

InflammationNrf2-mediated Ho-1 PathwayAnti-inflammatoryMedicineImmunologyPharmacologyBv2 Microglial CellsBrain-immune InteractionNeuroprotectionImmune FunctionNf-κb PathwayNeuroimmunologyNitrosative StressOxidative StressNeuroinflammation